What Happened?
, -based Vigil Neuroscience Appointed Adrianus Martens as Associate Director, Financial Planning and Analysis
About the Company
Vigil Neuroscience is the world`s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain`s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
About the Person
Adrianus Martens is Associate Director, Financial Planning and Analysis at Vigil Neuroscience. Previously, Adrianus held various senior HR leadership roles in the industry.
Info Source
News
Short Profile